MAISi

​SimpleTrials is an on-demand, subscription-based Clinical Trial Management System (CTMS) designed for sponsors, Contract Research Organizations (CROs), and investigative sites. It offers a comprehensive suite of tools to effectively plan, manage, and track clinical study portfolios, including features such as site startup and subject tracking, document management with integrated electronic Trial Master File (eTMF), real-time study analytics, calendar and monitoring, custom fields and trackers, ad-hoc reporting, planning and milestones, site contracts and payments, and electronic visit reports. It supports compliance with 21 CFR Part 11 and provides a secure, validated environment for clinical trial data. Users can customize tracking views, integrate with various Electronic Data Capture (EDC) systems, and utilize built-in templates for consistent document management.

Science 37 is a clinical research company specializing in decentralized clinical trials through its Metasite model, which eliminates physical proximity as a barrier, enabling patients to participate from anywhere. This approach expands access to over 90% of patients who are unable to participate in traditional site-based research, offering the recruiting power of 20 sites in one and providing the flexibility patients need to participate from anywhere. The Metasite is powered by a proprietary platform that drives uniform study orchestration, guiding the workflow of patients and study staff, and capturing study data without the need for manual reentry. This centralization of people, processes, and platforms delivers built-in protocol compliance, ensuring greater compliance and high-quality data. Science 37's in-house medical teams, telemedicine investigators, and mobile nurses have extensive experience in remote trial conduct across various therapeutic areas, ensuring broad reach.